Master-limited partnership Enterprise Products Partners (NYSE: EPD) and its nearly 8% yield are a perfect example of how consistent growth and a beefy dividend can help investors crush inflation. The beauty of a successful rare disease operating model is that competition is virtually nonexistent, and insurance companies don't push back on high list prices. Medical marijuana-focused real estate investment trust (REIT) Innovative Industrial Properties (NYSE: IIPR) has the potential to more than double its revenue over the next two years, all while parsing out a $5.60 base annual payout, equating to a 2.4% yield.